Fb. Davis et al., INOSITOL PHOSPHATES MODULATE BINDING OF THYROID-HORMONE TO HUMAN RED-CELL MEMBRANES IN-VITRO, The Journal of clinical endocrinology and metabolism, 77(5), 1993, pp. 1427-1430
D-Myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P-3] and D-myo-inositol
4,5-bisphosphate (10(-6) mol/L) displaced specifically bound L-[I-125]
T-4 from human erythrocyte membranes in vitro by up to 80%. D-Myo-ino
sitol 1,3,4,5-tetrakisphosphate, D-myo-inositol 1-monophosphate, and D
-myo-inositol 1,4-bisphosphate were ineffective in decreasing thyroid
hormone binding to membranes. The effect of Ins(1,4,5)P-3 on high affi
nity binding reflected a change in K-d (5.8 x 10(-11) vs. 1.5 x 10(-11
) mol/L) and binding capacity (15 vs. 2 fmol/mg membrane protein) in t
he absence and presence of Ins(1,4,5)P-3, respectively. Ins(1,4,5)P-3
also displaced T-3 from red cell membranes. Thus, selected inositol ph
osphates regulate the abundance of sites available for binding of thyr
oid hormone by human red cell membranes. This stereospecific action of
inositol phosphates is among several plasma membrane effects recently
described for these members of the signal-transducing phosphoinositid
e pathway.